Product News
Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay
Revvity, Inc. (NYSE: RVTY), announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus.
Product News
BIOHIT Introduces the FAEX™ Sample System for Stool Sample Collection and Handling
BIOHIT OYJ is excited to announce the launch of the BIOHIT FAEX Sample System, a stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic workflow.
Product News
Landmark Study at Homerton University Hospital Confirms GastroPanel®’s Diagnostic Accuracy
BIOHIT HealthCare is pleased to announce that a clinical study conducted by Homerton University Hospital NHS Foundation Trust, London, has confirmed the diagnostic accuracy of GastroPanel in identifying gastric cancer risk in patients.
Product News
Thermo Fisher Scientific Announces 510(k) Clearance of Molecular Clinical Test for SARS-CoV-2, Flu A, Flu B and RSV
Thermo Fisher Scientific has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel.
Product News
PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing To Help Advance Rare Disease Diagnostics
PacBio (NASDAQ: PACB), announced a significant publication from Radboud University Medical Center (Radboudumc) and its research partners in the American Journal of Human Genetics.
Product News
Spear Bio Secures FDA Breakthrough Device Designation for its Novel pTau 217 Blood Test, Advancing Scalable Solutions for Early Alzheimer's Disease Diagnosis
Spear Bio Inc., announced that its pTau 217 blood test has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
Advertisement
